Dentsply SironaXRAY +2.13%55 Days Payable is 56.30 as of Mar. 2026, which is 3% above its 10-year median of 54.47. GuruFocus rates XRAY with a GF Score™ of 55/100 and a GF Value™ of $19.05 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Dentsply Sirona ranks worse than 63.77% on this metric.
The historical rank and industry rank for Dentsply Sirona's Days Payable or its related term are showing as below:
XRAY'
s Days Payable Range Over the Past 10 Years
Min: 37.31 Med: 54.47 Max: 66.15
Current: 53.24
During the past 13 years, Dentsply Sirona's highest Days Payable was 66.15. The lowest was 37.31. And the median was 54.47.
XRAY's Days Payable is ranked worse than 63.77% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 67.87
vs XRAY: 53.24
Dentsply Sirona's Days Payable
declined
from Mar. 2025 (57.11) to Mar. 2026 (56.30).
It may suggest that Dentsply Sironaaccelerated paying its suppliers.
Dentsply Sirona Days Payable Related Terms
Dentsply Sirona Days Payable Historical Data
* Premium members only.
The historical data trend for Dentsply Sirona's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Dentsply Sirona's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dentsply Sirona Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Dentsply Sirona's Days Payable distribution charts can be found below:
* The bar in red indicates where Dentsply Sirona's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Dentsply Sirona's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dentsply Sirona (XRAY) has a Days Payable of 56.30 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Dentsply Sirona and its competitors. This is near median its historical median of 54.47. Over the past decade, Dentsply Sirona's Days Payable has ranged from 37.31 to 66.15. According to the industry distribution chart, Dentsply Sirona ranks #507 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 63.8%.
Is Dentsply Sirona's Days Payable too high?
Dentsply Sirona's current Days Payable of 56.30 is near median its 10-year median of 54.47. Over the past 10 years, this metric has ranged from a low of 37.31 to a high of 66.15. The Medical Devices & Instruments industry median Days Payable is 67.87. Dentsply Sirona's value of 56.30 is 17% below this industry median. Based on the distribution chart, Dentsply Sirona ranks #507 out of 795 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Dentsply Sirona has a GF Score™ of 55/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Dentsply Sirona's Days Payable compare to LMAT and PLSE?
According to the Medical Devices & Instruments industry distribution chart, Dentsply Sirona ranks #507 out of 795 companies for Days Payable. This places Dentsply Sirona in the lower half of its industry. The industry median Days Payable is 67.87. Dentsply Sirona's value of 56.30 is 17% below this benchmark. Historically, Dentsply Sirona's own Days Payable has ranged from 37.31 to 66.15 over the past decade. While the company's 10-year median is 54.47 vs. the industry median of 67.87, Dentsply Sirona has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.87, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dentsply Sirona's current Days Payable of 56.30 is 17% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Dentsply Sirona and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dentsply Sirona's current Days Payable is 56.30, which is near median its own 10-year median of 54.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dentsply Sirona stock overvalued right now?
Based on GuruFocus' analysis, Dentsply Sirona (XRAY) is currently considered Possible Value Trap. The stock's GF Value™ is $19.05, compared to a current price of $11.02 — trading 42.2% below its estimated fair value. The current Days Payable is 56.30, which is near median its 10-year median of 54.47 and 17% below the Medical Devices & Instruments industry median of 67.87. Dentsply Sirona's overall GF Score™ is 55/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Dentsply Sirona (XRAY), the current Days Payable is 56.30 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dentsply Sirona (XRAY) Overvalued in 2026?
Based on GuruFocus' analysis, Dentsply Sirona stock appears to be undervalued.
The current stock price of $11.02 is trading 42.2% below its estimated GF Value™ of $19.05.
GuruFocus considers Dentsply Sirona to be Possible Value Trap.
Key valuation signals for XRAY:
Days Payable: 56.30 (near median its 10-year median of 54.47)
GF Value™: $19.05 vs. price of $11.02 (42.2% below fair value)
Industry Position: 17% below the Medical Devices & Instruments median (#507 of 795)
No single metric tells the full story. See the XRAY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (dental consumables and lab products) and Sirona Dental Systems (technologically advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology, and equipment through third-party distributors. The remaining portfolio is sold to labs and offices through the firm's salesforce or directly to consumers (such as the Byte clear aligner).
55GF Score
Get the complete analysis for XRAY
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XRAY has been successfully added to your 
